JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB239007

Anti-Collagen II antibody [EPR12268] - BSA and Azide free

Be the first to review this product! Submit a review

|

(14 Publications)

Rabbit Recombinant Monoclonal Collagen II antibody. Carrier free. Suitable for WB and reacts with Human, Rat samples. Cited in 14 publications.

View Alternative Names

Collagen alpha-1(II) chain, Alpha-1 type II collagen, COL2A1

3 Images
Western blot - Anti-Collagen II antibody [EPR12268] - BSA and Azide free (AB239007)
  • WB

Lab

Western blot - Anti-Collagen II antibody [EPR12268] - BSA and Azide free (AB239007)

Actual band size : 30kDa (possible isoform or fragment) Blocking and diluting buffer : 5% NFDM/TBST. This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab188570).

All lanes:

Western blot - Anti-Collagen II antibody [EPR12268] (<a href='/en-us/products/primary-antibodies/collagen-ii-antibody-epr12268-ab188570'>ab188570</a>) at 1/5000 dilution

Lane 1:

Rat cartilage lysate at 20 µg

Lane 2:

Human cartilage lysate at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 141 kDa

Observed band size: 36 kDa

false

Western blot - Anti-Collagen II antibody [EPR12268] - BSA and Azide free (AB239007)
  • WB

Supplier Data

Western blot - Anti-Collagen II antibody [EPR12268] - BSA and Azide free (AB239007)

Actual band size : 30 kDa (possible isoform or fragment).

Negative control : liver (PMID : 31553813, PMID : 9121483).

Blocking and diluting buffer : 5% NFDM/TBST.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab188570).

All lanes:

Western blot - Anti-Collagen II antibody [EPR12268] (<a href='/en-us/products/primary-antibodies/collagen-ii-antibody-epr12268-ab188570'>ab188570</a>) at 1/5000 dilution

Lane 1:

Rat articular cartilage lysate at 20 µg

Lane 2:

Rat liver lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 30 kDa

false

Exposure time: 10s

Western blot - Anti-Collagen II antibody [EPR12268] - BSA and Azide free (AB239007)
  • WB

CiteAb

Western blot - Anti-Collagen II antibody [EPR12268] - BSA and Azide free (AB239007)

Collagen II western blot using anti-Collagen II antibody [EPR12268] - BSA and Azide free ab239007. Publication image and figure legend from Wu, Y., Zhang, H., et al., 2020, J Transl Med, PubMed 32448279.

ab239007 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab239007 please see the product overview.

Expression of KAT6B downstream molecules. qPCR was performed to measure the expression of RUNX2 (a), RUNX3 (b), COL2A1 (c), and COL10A1 (d) in primary chondrocytes from control (N = 10) and CS (N = 13) groups. e Western blot was performed to measure the expression of RUNX2, RUNX3, COL2A1, and COL10A1 in primary chondrocytes from control and CS groups. CS, congenital scoliosis. *p < 0.05

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR12268

Isotype

IgG

Carrier free

Yes

Reacts with

Rat, Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

ab239007 is the carrier-free version of ab188570.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Collagen type II also known as collagen II or native type II collagen is a fibrillar collagen essential in the formation of cartilage. It has a molecular mass of about 300 kDa. This protein is widely expressed in cartilaginous tissues including the extracellular matrix (ECM) of hyaline cartilage which makes up a significant part of the cartilage in joints and intervertebral discs. Collagen type II provides tensile strength and structural support to these tissues facilitating normal function and joint stability.
Biological function summary

Fibrillar collagen type II is an important component of the extracellular matrix important for endochondral ossification and cartilage formation. Collagen type II forms a network that interacts with other ECM molecules such as proteoglycans and non-collagenous proteins creating a hydrated gel that resists compressive forces. This complex structure is essential for maintaining the biomechanical properties of cartilage enabling it to withstand mechanical stress and support smooth joint movements.

Pathways

Collagen type II plays an important role in cartilage development and homeostasis. It is integral to the TGF-β signaling pathway which regulates cell growth and differentiation in chondrocytes. The protein is related to other collagens such as collagen type IX and proteoglycans like aggrecan both of which contribute to the structural integrity of cartilage. These interactions facilitate the proper assembly and organization of cartilage ECM supporting tissue function.

Collagen type II has a significant association with osteoarthritis and rheumatoid arthritis. In these degenerative conditions the degradation of collagen type II leads to cartilage breakdown and joint pain. Furthermore autoimmune response against collagen type II can occur as seen in rheumatoid arthritis where anti-collagen antibodies target the protein worsening joint inflammation. The protein's impairment or structural alteration may also involve interactions with degradative enzymes like matrix metalloproteinases exacerbating disease progression.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Type II collagen is specific for cartilaginous tissues. It is essential for the normal embryonic development of the skeleton, for linear growth and for the ability of cartilage to resist compressive forces.
See full target information COL2A1

Publications (14)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in pharmacology 15:1336282 PubMed38576477

2024

PPARδ agonist protects against osteoarthritis by activating AKT/mTOR signaling pathway-mediated autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Guantong Sun,Xiaodong Li,Pengcheng Liu,Yao Wang,Cheng Yang,Shuhong Zhang,Lei Wang,Xiaoqing Wang

Cell death & disease 13:932 PubMed36344492

2022

CircFOXO3 protects against osteoarthritis by targeting its parental gene FOXO3 and activating PI3K/AKT-mediated autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Chen Zhao,Xiaodong Li,Guantong Sun,Pengcheng Liu,Keyu Kong,Xuzhuo Chen,Fei Yang,Xiaoqing Wang

Computational intelligence and neuroscience 2022:1447129 PubMed36093506

2022

Comparison of the Effects of Open Surgery and Minimally Invasive Surgery on the Achilles Tendon Rupture Healing Based on Angiogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Fan Gong,Xiaoliang Li,Hanling Zhang,Jianke Wu,Guoxu Ma,Bowen Zhang,Jian Gao,Yi Ding,Yonglu Huang,Suoli Cheng,Xuebing Zhou,Fei Zhao

Central-European journal of immunology 46:305-313 PubMed34764802

2021

Tim-1 alleviates lupus nephritis-induced podocyte injury via regulating autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Yunxia Yu,Caixia Zhu,Nan Yu,Lijuan Yang

Experimental and therapeutic medicine 22:1247 PubMed34539843

2021

LINC00473 exacerbates osteoarthritis development by promoting chondrocyte apoptosis and proinflammatory cytokine production through the miR-424-5p/LY6E axis.

Applications

Unspecified application

Species

Unspecified reactive species

Guiyong Fan,Jinlian Liu,Yesong Zhang,Xinxian Guan

Journal of nanobiotechnology 19:194 PubMed34193158

2021

Mesenchymal stem cell-derived extracellular vesicles prevent the development of osteoarthritis via the circHIPK3/miR-124-3p/MYH9 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Shenglong Li,Jie Liu,Siyu Liu,Weijie Jiao,Xiaohong Wang

The journal of gene medicine 23:e3314 PubMed33491257

2021

LINC02288 promotes chondrocyte apoptosis and inflammation through miR-374a-3p targeting RTN3.

Applications

Unspecified application

Species

Unspecified reactive species

Qiwei Fu,Jun Zhu,Bo Wang,Jun Wu,Haobo Li,Yaguang Han,Dong Xiang,Yi Chen,Lexiang Li

Cell death & disease 12:13 PubMed33414452

2021

STING promotes senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the NF-κB signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Qiang Guo,Ximiao Chen,Jiaoxiang Chen,Gang Zheng,Chenglong Xie,Hongqiang Wu,Zhimin Miao,Yan Lin,Xiangyang Wang,Weiyang Gao,Xiangtao Zheng,Zongyou Pan,Yifei Zhou,Yaosen Wu,Xiaolei Zhang

FEBS open bio 10:2656-2665 PubMed33058414

2020

Platelet lysate induces chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells by regulating the lncRNA H19/miR-29b-3p/SOX9 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Boran Cao,Xin Dai

Molecular medicine reports 22:3621-3628 PubMed32901887

2020

MicroRNA‑25‑3p regulates human nucleus pulposus cell proliferation and apoptosis in intervertebral disc degeneration by targeting Bim.

Applications

Unspecified application

Species

Unspecified reactive species

Zhifang Zhao,Jie Zheng,Youchen Ye,Kefeng Zhao,Ruozhang Wang,Ran Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com